Iran Antibiotic Manufacturing (IAMZ) More Than Doubles Six-Month Profit to 3,152 Billion Rials on 19% Revenue Growth, Close to All of Fiscal 1404
Sahmino Newsroom | 19 November 2026 | yesterday
In its standalone income statement for the six months to 31 Shahrivar 1405 (22 September 2026), filed on Codal on 18 November 2026, Iran Antibiotic Manufacturing (IAMZ) reported operating revenue of 10,376 billion rials, up 19% from 8,743 billion rials in the same period a year earlier (restated).
Cost of sales was almost flat, up 2% to 5,480 billion rials, so gross profit grew 44% to 4,896 billion rials and the gross margin rose from 38.8% to 47.2%. Operating profit is 4,802 billion rials (up 45%), while finance costs went from 444 billion rials to 749 billion rials.
Current-year income tax fell from 1,422 billion rials to 982 billion rials and net profit reached 3,152 billion rials, 119% above 1,442 billion rials in the same period a year earlier. Basic earnings per share went from 1,799 to 3,934 rials, and the six-month profit equals 98% of the full-year profit for fiscal 1404 (3,209 billion rials). Share capital is 803 billion rials.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
From Sahmino that week
The PLSH Refinery Fund Still Trades 26% Below Its Net Asset Value, a Discount That Has Narrowed Since September (Friday 20 November 2026)
Article | 20 NovemberPrice, Not Tonnage: NALM Sold Less Aluminium Over Seven Months Yet More Than Doubled Its Sales (Thursday 19 November 2026)
Article | 19 NovemberDividend payment: BAHN
Calendar | 19 NovemberDividend payment: LEAB
Calendar | 19 November
More from this market
Darupakhsh Factories (DPAK) Lifts Six-Month Net Profit 7.2-Fold to 60,998 Billion Rials at a 66.1% Gross Margin
Stocks | 9 hours agoIran Commodity Exchange (KALA) Lifts Six-Month Net Profit 190% to 42,953 Billion Rials, Close to Last Full Year's Profit
Stocks | 3 days agoIran Fara Bourse Company Posts 6,099 Billion Rial Net Profit for the First Half of 1405
Stocks | last monthDarupakhsh Pharmaceutical Raw Materials (TMVD) Books 18,401 Billion Rials of Six-Month Net Profit, Up 248% and 148% of All of Fiscal 1404
Stocks | yesterday
